AU Stock MarketDetailed Quotes
MXCDA MGC Pharmaceuticals Ltd
- 0.475
- 0.0000.00%
20min DelayMarket Closed Nov 7 16:00 AET
2.10MMarket Cap-0.07P/E (Static)
0.000High0.000Low0Volume0.000Open0.475Pre Close0.00Turnover0.47552wk High0.00%Turnover Ratio4.43MShares0.42052wk Low-7.1EPS TTM1.86MFloat Cap1.000Historical HighLossP/E (Static)3.92MShs Float0.410Historical Low-7.1EPS LYR0.00%Amplitude--Dividend TTM-0.28P/B1Lot Size--Div YieldTTM
MGC Pharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||
| Cash income from operating activities | 19.51%2.55M | -20.78%2.14M | 295.09%2.7M | 12.45%-1.38M | -1.58M |
| Revenue from customers | -37.92%3.96M | 194.89%6.38M | 4.37%2.16M | 110.34%2.07M | --985.2K |
| Income from government grants | ---- | --650 | ---- | ---- | ---- |
| Other cash income from operating activities | 66.87%-1.41M | -893.59%-4.24M | 115.47%534.53K | -34.72%-3.45M | ---2.56M |
| Cash paid | 8.09%-13.12M | 2.84%-14.27M | -73.76%-14.69M | -72.32%-8.45M | -4.91M |
| Payments to suppliers for goods and services | 8.09%-13.12M | 2.84%-14.27M | -73.76%-14.69M | -72.32%-8.45M | ---4.91M |
| Direct interest paid | 91.48%-2.17K | -244.05%-25.45K | 94.54%-7.4K | -30,436.49%-135.58K | ---444 |
| Direct interest received | 14,382.06%43.59K | -96.23%301 | -43.94%7.98K | -91.00%14.24K | --158.19K |
| Direct tax refund paid | ---- | ---- | ---- | ---- | ---27.32K |
| Operating cash flow | 13.47%-10.52M | -1.41%-12.16M | -20.42%-11.99M | -56.70%-9.96M | ---6.35M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | 104.66%51.75K | 25.61%-1.11M | -54.02%-1.49M | -2.41%-969.88K | -947.04K |
| Net PPE purchase and sale | 72.57%-738.67K | -207.31%-2.69M | 8.39%-876.36K | -153.72%-956.63K | ---377.04K |
| Net business purchase and sale | ---- | 98.78%-4.55K | -2,716.55%-373.25K | 97.68%-13.25K | ---569.99K |
| Net investment purchase and sale | ---- | ---- | --302.82K | ---- | ---- |
| Net other investing changes | -50.18%790.42K | 390.03%1.59M | ---547K | ---- | ---- |
| Cash from discontinued investing activities | |||||
| Investing cash flow | 104.66%51.75K | 25.61%-1.11M | -54.02%-1.49M | -2.41%-969.88K | ---947.04K |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | -4.38%9.31M | -42.89%9.74M | 62.98%17.05M | 38,627.72%10.46M | 27.01K |
| Net issuance payments of debt | 11,406.97%7.07M | -98.93%61.42K | --5.75M | ---- | ---- |
| Net common stock issuance | -73.67%2.62M | -14.00%9.94M | 1.08%11.56M | 42,223.21%11.43M | --27.01K |
| Net other financing activities | -42.19%-373.97K | -2.74%-263.01K | 73.64%-255.99K | ---971.29K | ---- |
| Cash from discontinued financing activities | |||||
| Financing cash flow | -4.38%9.31M | -42.89%9.74M | 62.98%17.05M | 38,627.72%10.46M | --27.01K |
| Net cash flow | |||||
| Beginning cash position | -65.28%1.89M | 190.02%5.43M | -20.42%1.87M | -76.12%2.35M | --9.86M |
| Current changes in cash | 67.21%-1.16M | -198.99%-3.53M | 867.49%3.57M | 93.61%-464.85K | ---7.27M |
| Effect of exchange rate changes | -3,093.19%-488.46K | -96.14%-15.3K | 50.85%-7.8K | 93.12%-15.87K | ---230.66K |
| End cash Position | -87.29%239.82K | -65.28%1.89M | 190.02%5.43M | -20.42%1.87M | --2.35M |
| Free cash from | 24.19%-11.26M | 3.04%-14.85M | -40.28%-15.32M | -62.57%-10.92M | ---6.72M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Heat List
AU
Overall
Symbol
Price
% Chg
No Data